dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Schuler, Martin |
dc.contributor.author | Berardi, R. |
dc.contributor.author | Lim, Darren Wan-Teck |
dc.contributor.author | de Jonge, M. |
dc.contributor.author | Azaro Pedrazzoli, Analía Beatriz |
dc.contributor.author | Bauer, Todd |
dc.date.accessioned | 2021-10-20T08:03:21Z |
dc.date.available | 2021-10-20T08:03:21Z |
dc.date.issued | 2020-06 |
dc.identifier.citation | Schuler M, Berardi R, Lim WT, de Jonge M, Bauer TM, Azaro A, et al. Molecular correlates of response to capmatinib in advanced non–small-cell lung cancer: clinical and biomarker results from a Phase I trial. Ann Oncol. 2020 Jun;31(6):789–97. |
dc.identifier.issn | 0923-7534 |
dc.identifier.uri | https://hdl.handle.net/11351/6421 |
dc.description | Mutació del MET; Capmatinib |
dc.description.sponsorship | This study was funded by Novartis Pharmaceuticals Corporation. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Annals of Oncology;31(6) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Aspectes genètics |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | Lung Neoplasms |
dc.subject.mesh | Mutation |
dc.title | Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.annonc.2020.03.293 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | neoplasias pulmonares |
dc.subject.decs | mutación |
dc.relation.publishversion | https://doi.org/10.1016/j.annonc.2020.03.293 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Schuler M] Department of Medical Oncology, West German Cancer Center, University Duisburg-Essen, Essen, Germany. German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. [Berardi R] Clinica Oncologica, Università Politecnica delle Marche—Ospedali Riuniti, Ancona, Italy. [Lim WT] Division of Medical Oncology, National Cancer Centre Singapore, Singapore. [de Jonge M] Medical Oncology, Erasmus MC Cancer Center, Rotterdam, The Netherlands. [Bauer TM] Drug Development Unit, Sarah Cannon Research Institute, and Tennessee Oncology, PLCC, Nashville, USA. [Azaro A] Unitat d’Investigació de Teràpia Molecular, Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Farmacologia, Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 32240796 |
dc.identifier.wos | 000535705600012 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |